{"apiVersion":"v1","taxonomyVersion":1,"generatedAt":"2026-10-29T15:01:47.007Z","data":{"recordId":"wsa_2dkcpdaqc7za","score":0.806,"confidence":"high","capped":false,"capReason":null,"sources":[{"n":1,"url":"https://www.anthropic.com/news/improving-fable-5-s-biology-safeguards","publisher":"Anthropic","authority":"owner-controlled","verification":"verified","lastRetrievedAt":"2026-10-28T00:27:38.878Z","detectedPublishedAt":"2026-08-07T00:00:00.000Z","rights":"original"}],"claims":[{"id":"d5360cc7-cbac-427a-8caf-8962217bd467","kind":"capability","statement":"In testing, the update reduced biology-related fallbacks by about 85%.","citations":[{"source":1,"supportProbability":0.98,"supports":true,"quote":{"text":"In our testing, this update reduced biology-related fallbacks by about 85% across our product surfaces.","rights":"original"}}]},{"id":"4ee50332-4618-4267-9caa-2c7f84d1faa8","kind":"availability","statement":"The update applies across Claude.ai, Cowork, Claude Code, and Claude Platform.","citations":[{"source":1,"supportProbability":0.67,"supports":false,"quote":{"text":"01 As a result, we expect the total number of fallbacks—for biology–related or any other reasons—will also be reduced: by roughly 67% on Claude.ai , 55% on Cowork, 17% on Claude Code, and 7% on the Claude Platform.","rights":"original"}}]},{"id":"aaef3524-8714-4b6d-b116-2b117c982cb0","kind":"capability","statement":"The updated safeguards allow a wider range of benign biology requests.","citations":[{"source":1,"supportProbability":0.97,"supports":true,"quote":{"text":"We then developed updated training data for the classifier based on that constitution, and retrained it, and verified the new classifier would still generally trigger for harmful and dual-use research biology content but would now enable a wider range of benign and beneficial…","rights":"original"}}]},{"id":"0ce4de3e-d5ed-40e5-9004-cb9a61bca38d","kind":"capability","statement":"Fable 5 continues to fall back to Opus 5 for requests considered dual-use, including virology, toxicology, and molecular design.","citations":[{"source":1,"supportProbability":0.97,"supports":true,"quote":{"text":"Today, Fable still falls back to Opus 5 for requests we consider dual-use—including virology, toxicology, and molecular design—so it isn't yet usable for professional biology research and drug development.","rights":"original"}}]}]},"nextCursor":null,"license":{"catalog":{"name":"CC BY 4.0","spdx":"CC-BY-4.0","url":"https://creativecommons.org/licenses/by/4.0/","attribution":"wowsuchai","attributionUrl":"https://wowsuchai.withglint.app","covers":["catalog metadata","classifications","generated summaries","feed event metadata"]},"excluded":{"covers":["source quotations","linked source content"],"terms":"Not licensed by wowsuchai. Source quotations and linked source content keep their original rights."}}}